Related references
Note: Only part of the references are listed.The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice
He Zhu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Gehua Jiecheng Decoction Inhibits Diethylnitrosamine-Induced Hepatocellular Carcinoma in Mice by Improving Tumor Immunosuppression Microenvironment
Changpei Cheng et al.
FRONTIERS IN PHARMACOLOGY (2020)
Trajectory and Functional Analysis of PD-1high CD4+CD8+ T Cells in Hepatocellular Carcinoma by Single-Cell Cytometry and Transcriptome Sequencing
Bo Zheng et al.
ADVANCED SCIENCE (2020)
Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study
He-tong Zhao et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2020)
Efficacy and Safety of Banxia XieXin Decoction, a Blended Traditional Chinese Medicine, as Monotherapy for Patients With Advanced Hepatocellular Carcinoma
Lijuan Wang et al.
INTEGRATIVE CANCER THERAPIES (2020)
Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung
Caroline Laheurte et al.
BRITISH JOURNAL OF CANCER (2019)
TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma
Xiaochen Wang et al.
JOURNAL OF HEPATOLOGY (2019)
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Omar Khan et al.
NATURE (2019)
Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma
XiaoLi Liu et al.
PHYTOMEDICINE (2019)
PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma
Xiaoli Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells
Mengyun Ke et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
Jiaqiang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Projections of primary liver cancer to 2030 in 30 countries worldwide
Patricia C. Valery et al.
HEPATOLOGY (2018)
Novel approaches for molecular targeted therapy against hepatocellular carcinoma
Yuji Eso et al.
HEPATOLOGY RESEARCH (2018)
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Kristian M. Hargadon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Polysaccharides from Chinese Herbal Lycium barbarum Induced Systemic and Local Immune Responses in H22 Tumor-Bearing Mice
Xiangliang Deng et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
PD-1+TIM-3+T cells in malignant ascites predict prognosis of gastrointestinal cancer
Michitaka Nakano et al.
CANCER SCIENCE (2018)
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
Hyung-Don Kim et al.
GASTROENTEROLOGY (2018)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
The phenolic profiles of Radix Tetrastigma after solid phase extraction (SPE) and their antitumor effects and antioxidant activities in H22 tumor-bearing mice
Yong Sun et al.
FOOD & FUNCTION (2017)
Phase III multi-centre open-label randomized controlled trial of selective internal radiation therapy (SIRT) versus sorafenib in locally advanced hepatocellular carcinoma: The SIRveNIB study.
Pierce H. W. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8+ T Cell Exhaustion
Bertram Bengsch et al.
IMMUNITY (2016)
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
John Attanasio et al.
IMMUNITY (2016)
Anti-angiogenic therapy for normalization of tumor vasculature: A potential effect of Buyang Huanwu decoction on nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential
Liang Min et al.
MOLECULAR MEDICINE REPORTS (2016)
A molecular threshold for effector CD8+ T cell differentiation controlled by transcription factors Blimp-1 and T-bet
Annie Xin et al.
NATURE IMMUNOLOGY (2016)
The epigenetic landscape of T cell exhaustion
Debattama R. Sen et al.
SCIENCE (2016)
Why cancer screening has never been shown to save lives-and what we can do about it
Vinay Prasad et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Why cancer screening has never been shown to save lives-and what we can do about it
Vinay Prasad et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Characterization of T-bet and eomes in Peripheral Human immune Cells (vol 5, 217, 2014)
James J. Knox et al.
FRONTIERS IN IMMUNOLOGY (2016)
Overcoming T cell exhaustion in infection and cancer
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2015)
Sorafenib Combined with Transarterial Chemoembolization versus Transarterial Chemoembolization Alone for Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Study
Hao Hu et al.
PLOS ONE (2014)
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
Alessandro Cucchetti et al.
JOURNAL OF HEPATOLOGY (2013)
Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection
Charlly Kao et al.
NATURE IMMUNOLOGY (2011)
Cutting Edge: The Transcription Factor Eomesodermin Enables CD8+ T Cells To Compete for the Memory Cell Niche
Arnob Banerjee et al.
JOURNAL OF IMMUNOLOGY (2010)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
E. John Wherry et al.
IMMUNITY (2007)
Share Paper
